PARTNERS

Partner With
Radical Numerics

We work with researchers, companies and institutions to apply Omnii to consequential biological problems — from understanding disease to strengthening biosecurity.

TRUSTED BY RESEARCH AND INDUSTRY PARTNERS

  • Lawrence Livermore
    National Laboratory
  • Flock Bio
  • ClearNote Health

PARTNERSHIP AREAS

Where We Partner.

Four areas where Omnii’s ability to read, write and interpret biology changes what a partnership can deliver.

01 / 04

Drug Discovery.

Predict how targets and candidate molecules behave before the wet lab. We work with discovery teams to prioritise targets, anticipate effects and design better candidates.

02 / 04

Diagnostics.

Find disease signals earlier and more reliably. Omnii brings sequence, imaging and clinical context together for detection that limits false positives.

03 / 04

Synthetic Biology.

Design biological systems for new functions — from proteins that selectively bind rare-earth metals to optimised mRNA vaccine sequences.

04 / 04

Biodefense.

Assess what a sequence does, not just what it resembles. We partner with biosecurity teams to strengthen defences against biological threats.

PARTNERSHIP MODEL

How We Work Together.

Every partnership starts with a problem worth solving. We scope it together, build with Omnii, and validate against your data.

  1. STEP 01

    Define the Problem.

    We start from your question, your data and what success looks like — and agree where Omnii can make a measurable difference.

  2. STEP 02

    Build With Omnii.

    Our team adapts Omnii to your problem — fine-tuning on your data, designing experiments and iterating with your scientists.

  3. STEP 03

    Validate Together.

    Results are tested against your benchmarks and, where it matters, in the lab — so what we ship holds up in the real world.

Start a conversation

WORK WITH RADICAL NUMERICS

We work with researchers, companies, and institutions to apply Omnii to challenges across disease, therapeutics, and biosecurity.

All biological specifications and data inquiries are strictly confidential.